Feroniellin A-induced autophagy causes apoptosis in multidrug-resistant human A549 lung cancer cells

International Journal of Oncology

Volumn 44, Issue 4, 2014, Pages 1233-1242

  Kaewpiboon, Chutima ^a   Surapinit, Serm ^a   Malilas, Waraporn ^b   Moon, Jeong ^b   Phuwapraisirisan, Preecha ^a   Tip Pyang, Santi ^a   Johnston, Randal N ^c   Koh, Sang Seok ^d   Assavalapsakul, Wanchai ^a   Chung, Young Hwa ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Pusan National University   (South Korea)

^c UNIVERSITY OF CALGARY   (Canada)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Apoptosis; Autophagy; Feroniellin A; Multidrug resistance

Indexed keywords

3-(4-METHYLPHENYLSULFONYL)-2-PROPENENITRILE; ABCB1 PROTEIN, HUMAN; ACTIN BINDING PROTEIN; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; COUMARIN DERIVATIVE; ETOPOSIDE; FERONIELLOSIDE; FURAN DERIVATIVE; GLYCOSIDE; KLHL1 PROTEIN, HUMAN; MEMBRANE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; NITRILE; RAPAMYCIN; RELA PROTEIN, HUMAN; SMALL INTERFERING RNA; SULFONE; TRANSCRIPTION FACTOR RELA;

ANTAGONISTS AND INHIBITORS; APOPTOSIS; AUTOPHAGY; BIOSYNTHESIS; DRUG EFFECTS; DRUG RESISTANCE; GENETIC TRANSCRIPTION; GENETICS; HUMAN; LUNG NEOPLASMS; PROMOTER REGION; RNA INTERFERENCE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL LINE, TUMOR; COUMARINS; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FURANS; GLYCOSIDES; HUMANS; LUNG NEOPLASMS; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; NITRILES; P-GLYCOPROTEINS; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIROLIMUS; SULFONES; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC;

EID: 84894429613     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2297     Document Type: Article

References (50)

1. Tan G, Gyllenhaal C and Soejarto DD: Biodiversity as a source of anticancer drugs. Curr Drug Targets 7: 265-277, 2006.
2. Bronikowska J, Szliszka E, Jaworska D, Czuba ZP and Krol W: The coumarin psoralidin enhances anticancer effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Molecules 17: 6449-6464, 2012.
3. Diwan R and Malpathak N: Furanocoumarins: novel topoisomerase I inhibitors from Ruta graveolens L. Bioorg Med Chem 17: 7052-7055, 2009.
4. Ohnishi A, Matsuo H, Yamada S, et al: Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4. Br Pharmacol 130: 1369-1377, 2000.
5. Paine MF, Widmer WW, Hart HL, et al: A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction. Am J Clin Nutr 83: 1097-1105, 2006.
6. Biedler JL: Drug resistance: genotype versus phenotype - Thirty-second G.H.A. Clowes Memorial Award Lecture. Cancer Res 54: 666-678, 1994.
7. Bosch I and Croop J: P-glycoprotein multidrug resistance and cancer. Biochim Biophys Acta 9: 37-54, 1996.
8. Goldstein LJ, Galski H, Fojo A, et al: Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81: 116-124, 1989.
9. Gottesman MM, Fojo T and Bates SE: Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2: 48-58, 2002.
10. Friedrich K, Wieder T, Von Haefen C, et al: Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance. Oncogene 20: 2749-2760, 2001.
11. Ruefli AA, Tainton KM, Darcy PK, Smyth MJ and Johnstone RW: P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation. Cell Death Differ 9: 1266-1272, 2002.
12. Bentires-Alj M, Barbu V, Fillet M, et al: NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene 22: 90-97, 2003.
13. Chu F, Chou PM, Zheng X, Mirkin BL and Rebbaa A: Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1. Cancer Res 65: 10183-10187, 2005.
14. Klionsky DJ and Emr SD: Autophagy as a regulated pathway of cellular degradation. Science 290: 1717-1721, 2000.
15. Levine B and Klionsky DJ: Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6: 463-477, 2004.
16. Levine B and Kroemer G: Autophagy in the pathogenesis of disease. Cell 132: 27-42, 2008.
17. Qu X, Yu J, Bhagat G, et al: Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112: 1809-1820, 2003.
18. Levine B: Cell biology: autophagy and cancer. Nature 446: 745-747, 2007.
19. Takamura A, Komatsu M, Hara T, et al: Autophagy-deficient mice develop multiple liver tumors. Genes Dev 25: 795-800, 2011.
20. Han J, Hou W, Goldstein LA, et al: Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells. J Biol Chem 283: 19665-19677, 2008.
21. Katayama M, Kawaguchi T, Berger MS and Pieper RO: DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ 14: 548-558, 2007.
22. Li X and Fan Z: The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex. Cancer Res 70: 5942-5952, 2010.
23. Ogata M, Hino S, Saito A, et al: Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol 26: 9220-9231, 2006.
24. Kanintronkul Y, Worayuthakarn R, Thasana N, et al: Overcoming multidrug resistance in human lung cancer with novel benzo[α] quinolizin-4-ones. Anticancer Res 31: 921-927, 2011.
25. Phuwapraisirisan P, Surapinit S, Sombund S, Siripong P and Tip-pyang S: Feroniellins A-C, novel cytotoxic furanocoumarins with highly oxygenated C10 moieties from Feroniella lucida. Tetrahedron Lett 47: 3685-3688, 2006.
26. Kaewpiboon C, Lirdprapamongkol K, Srisomsap C, et al: Studies of the in vitro cytotoxic, antioxidant, lipase inhibitory and antimicrobial activities of selected Thai medicinal plants. BMC Complement Altern Med 12: 217, 2012.
27. Jung YJ, Lee JE, Lee AS, et al: SIRT1 overexpression decreases cisplatin-induced acetylation of NF-kappaB p65 subunit and cytotoxicity in renal proximal tubule cells. Biochem Biophys Res Commun 419: 206-210, 2012.
28. Sugimoto Y, Tsukahara S, Ishikawa E and Mitsuhashi J: Breast cancer resistance protein: molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics. Cancer Sci 96: 457-465, 2005.
29. Young LC, Campling BG, Cole SPC, Deeley RG and Gerlach JH: Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels. Clin Cancer Res 7: 1798-1804, 2001.
30. Kim HG, Hien TT, Han EH, et al: Metformin inhibits P-glycoprotein expression via the NF-kappaB pathway and CRE transcriptional activity through AMPK activation. Br J Pharmacol 162: 1096-1108, 2011.
31. Sun J, Yeung CA, Co NN, et al: Clitocine reversal of P-glycoprotein associated multi-drug resistance through downregulation of transcription factor NF-kappaB in R-HepG2 cell line. PLoS One 7: e40720, 2012.
32. Levy JM and Thorburn A: Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacol Ther 131: 130-141, 2011.
33. Yang ZJ, Chee CE, Huang S and Sinicrope FA: The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther 10: 1533-1541, 2011.
34. Jia YL, Li J, Qin ZH and Liang ZQ: Autophagic and apoptotic mechanisms of curcumin-induced death in K562 cells. J Asian Nat Prod Res 11: 918-928, 2009.
35. Dai ZJ, Gao J, Ma XB, et al: Antitumor effects of rapamycin in pancreatic cancer cells by inducing apoptosis and autophagy. Int J Mol Sci 14: 273-285, 2012.
36. Rubinsztein DC and Nixon RA: Rapamycin induces autophagic flux in neurons. Proc Natl Acad Sci USA 107: E181, 2010.
37. Hien TT, Kim HG, Han EH, Kang KW and Jeong HG: Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells. Mol Nutr Food Res 54: 918-928, 2010.
38. Tran TP, Kim HG, Choi JH, Na MK and Jeong HG: Reversal of P-glycoprotein-mediated multidrug resistance is induced by mollugin in MCF-7/adriamycin cells. Phytomedicine 20: 622-631, 2013.
39. Katerere DR and Eloff JN: Antibacterial and antioxidant activity of Sutherlandia frutescens (Fabaceae), a reputed anti-HIV/AIDS phytomedicine. Phytother Res 19: 779-781, 2005.
40. Zhang H, Zhang X, Wu X, et al: Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/beta-catenin pathway. Cancer Lett 323: 106-113, 2012.
41. Zhu H, Xia L, Zhang Y, et al: Activating transcription factor 4 confers a multidrug resistance phenotype to gastric cancer cells through transactivation of SIRT1 expression. PLoS One 7: e31431, 2012.
42. Denton D, Nicolson S and Kumar S: Cell death by autophagy: facts and apparent artefacts. Cell Death Differ 19: 87-95, 2012.
43. Kang HT, Lee KB, Kim SY, Choi HR and Park SC: Autophagy impairment induces premature senescence in primary human fibroblasts. PLoS One 6: e23367, 2011.
44. Tal MC, Sasai M, Lee HK, Yordy B, Shadel GS and Iwasaki A: Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc Natl Acad Sci USA 106: 2770-2775, 2009.
45. Selvakumaran M, Amaravadi RK, Vasilevskaya IA and O'Dwyer PJ: Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy. Clin Cancer Res 19: 2995-3007, 2013.
46. Shen J, Zheng H, Ruan J, et al: Autophagy inhibition induces enhanced proapoptotic effects of ZD6474 in glioblastoma. Br J Cancer 109: 164-171, 2013.
47. Yang PM, Liu YL, Lin YC, Shun CT, Wu MS and Chen CC: Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. Cancer Res 70: 7699-7709, 2010.
48. Wu Z, Chang PC, Yang JC, et al: Autophagy blockade sensitizes prostate cancer cells towards Src family kinase inhibitors. Genes Cancer 1: 40-49, 2010.
49. Josset E, Burckel H, Noel G and Bischoff P: The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line. Anticancer Res 33: 1845-1851, 2013.
50. Takeuchi H, Kondo Y, Fujiwara K, et al: Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res 65: 3336-3346, 2005.